Cryptococcus neoformans is the most common cause of fungal meningitis in HIV and non-
HIV-infected patients. The organism has a worldwide distribution, with cases typically …

Cryptococcal meningitis has emerged as one of the most frequent and deadly opportunistic
infections in patients with human immunodeficiency virus (HIV). Cryptococcosis has become …

Cryptococcal meningitis (CM) remains a serious cause of mortality and morbidity in
individuals infected with the human immunodeficiency virus (HIV). The optimal treatment of …

Objective: To compare the efficacy of fluconazole with amphotericin B plus flucytosine in the
treatment of cryptococcal meningitis. Design: Patients were randomly assigned to oral …

Introduction Cryptococcal meningitis is the most common neurological infection in HIV
infected patients in Sub Saharan Africa, where gold standard treatment with intravenous …

Infections caused by Cryptococcus neoformans cause significant morbidity and high
mortality, particularly among immunocompromised patients. Cryptococcal meningitis is an …

Cryptococcal meningitis is a leading cause of morbidity and mortality globally, especially in
people with advanced HIV disease. Cryptococcal meningitis is responsible for nearly 20% of …

Cryptococcal meningitis (CM) is the most fatal adult meningitis in patients with human
immunodeficiency virus (HIV). There is no conclusive evidence for the superiority of 1-week …

Background Treatment with low-dose amphotericin B (0.4 mg per kilogram of body weight
per day) or oral azole therapy in patients with the acquired immunodeficiency syndrome …

Abstract Background The 2010 Infectious Diseases Society of America (IDSA) guidelines for
management of cryptococcal diseases recommend high dose fluconazole (≥ 800 mg/day) …